News
AstraZeneca to build CGT center in Hong Kong
Global MarketsAstraZeneca to build CGT center in Hong KongAstraZeneca to build CGT center in Hong Kong
AstraZeneca plans to build a major R&D center in Hong Kong that will be devoted to developing cell and gene therapy drugs for global use.